Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Bio-Rad Laboratories B | BIO-B | 24. dec 2024 | 325.85 | 0.00 |
Bio-Techne | TECH | 24. dec 2024 | 73.03 | +0.40 |
BioAffinity Technologies | BIAF | 24. dec 2024 | 0.95 | -2.35 |
BioAge Labs | BIOA | 24. dec 2024 | 6.08 | 0.00 |
BioAtla | BCAB | 24. dec 2024 | 0.62 | +1.57 |
BioCardia | BCDA | 24. dec 2024 | 2.00 | -0.50 |
Bioceres Crop Solutions | BIOX | 24. dec 2024 | 6.32 | -0.16 |
BioCryst Pharmaceuticals | BCRX | 24. dec 2024 | 7.67 | -1.41 |
Biodesix | BDSX | 24. dec 2024 | 1.46 | -0.68 |
Biodexa Pharma ADR | BDRX | 24. dec 2024 | 4.29 | +12.29 |
Biofrontera | BFRI | 24. dec 2024 | 1.01 | 0.00 |
Biogen | BIIB | 24. dec 2024 | 149.02 | -0.24 |
BioHarvest Sciences | BHST | 24. dec 2024 | 6.10 | 0.00 |
Biohaven | BHVN | 24. dec 2024 | 35.75 | -1.11 |
BioLife Solutions | BLFS | 24. dec 2024 | 26.50 | +0.45 |
BioLineRX ADR | BLRX | 24. dec 2024 | 0.23 | +4.76 |
BioMarin Pharmaceutical | BMRN | 24. dec 2024 | 66.63 | +0.54 |
Biomea Fusion | BMEA | 24. dec 2024 | 4.01 | -0.50 |
Biomerica | BMRA | 24. dec 2024 | 0.28 | +2.21 |
BiomX | PHGE | 24. dec 2024 | 0.54 | -1.15 |
Bionano Genomics | BNGO | 24. dec 2024 | 0.20 | +0.35 |
BioNexus Gene Lab | BGLC | 24. dec 2024 | 0.24 | +4.61 |
Bionomics ADR | BNOX | 24. dec 2024 | 0.25 | 0.00 |
BioNTech ADR | BNTX | 24. dec 2024 | 114.13 | +0.55 |
Biora Therapeutics | BIOR | 24. dec 2024 | 0.56 | 0.00 |
BioRestorative Therapies | BRTX | 24. dec 2024 | 1.54 | +1.32 |
BioShares Biotechnology Clinical Trials Fund | BBC | 24. dec 2024 | 24.49 | +0.03 |
BioShares Biotechnology Products Fund | BBP | 24. dec 2024 | 60.56 | +0.11 |
biote | BTMD | 24. dec 2024 | 5.96 | +2.94 |
Bioventus A | BVS | 24. dec 2024 | 10.68 | +0.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.